DMS 79細胞 
	
		器官來源:	肺
	
	
		生長狀態:	懸浮生長,多細胞聚集
	
	
		ATCC Number:	CRL-2049?
	
	
		相關**:	小細胞肺癌
	
	
		是否是腫瘤細胞:	1
	
	
		物種來源:	人
	
	
		年限:	65 years
	
	
		運輸方式:	凍存運輸
	
	
		數量:	大量
	
	
		Designations:	DMS 79
	
	
		Depositors:	 OS Pettengill, G Sorenson
	
	
		Biosafety Level:	1
	
	
		DMS 79細胞Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	suspension, multicell aggregates
	
	
		Organism:	Homo sapiens
	
	
		Morphology:
	
	
		Source:	Organ: lung
	
	
		Disease: carcinoma; small cell lung cancer
	
	
		Cellular Products:	adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; calcitonin; corticotropin; beta endorphin; 17 beta estradiol; lipotropin; oxytocin - neurophysin (OT-NP); parathormone; somatostatin-like immunoreactivity (SRIF)
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Restrictions:	Note: DMS 79細胞These cells are distributed subject to the following: 1.) This cell line or its products must not be distributed to third parties. Commercial interests are the exclusive property of Dartmouth College. 2.) Any proposed commercial use of these cells must first be negotiated with Office of Technology Transfer, Dartmouth College, Hanover, NH, 03755. Tel: (603) 646-3675. 3.) In all papers reporting any use of these cells, or derived products, a direct reference will be made to the original publications.
	
	
		Receptors:	epidermal growth factor (EGF)
	
	
		Tumorigenic:	Yes
	
	
		Oncogene:	c-myc +; N-myc +; c-raf-1 +; H-ras +; K-ras +; N-ras +; v-fes -; v-fms -
	
	
		Antigen Expression:	Leu 7; My23
	
	
		DNA Profile (STR):	Amelogenin: X,Y
	
	
		CSF1PO: 10
	
	
		D13S317: 11
	
	
		D16S539: 12
	
	
		D5S818: 10
	
	
		D7S820: 9,11
	
	
		THO1: 8
	
	
		TPOX: 8
	
	
		vWA: 18
	
	
		Cytogenetic Analysis: DMS 79細胞Number of cells examined = 80; Modal Chromosome Number = 79 with a range of 65 to 84; Polyploidy Rate = 14.3%
	
	
		Age:	65 years
	
	
		Ethnicity:	Caucasian
	
	
		Comments:	The line was established from cells in the pleural fluid of a patient with small cell carcinoma of the lung.
	
	
		The patient had previously been treated with cytoxan, vincristine, methotrexate and radiation therapy.
	
	
		The cell express HLA class I and class II antigens.
	
	
		Derivative chromosomes observed at high frequency in 24 karyotyped metaphases included: der(2)t(2;?18)(q10;q10); del(3)?(pter-->p21::q10-->qter); del(6)(q13); der(10); add(11)(p15); der(14)t(14;17)(q10;q10); add(15)(p11); add(15)(p11)+; and del(17)(?q24).
	
	
		Two copies of each derivative chromosome was observed in each metaphase.
	
	
		Less frequent derivative chromosomes included: del(12)?(q11q21)[18/24 cells] and add(13)(p11)[10/24 cells]. Four to eight additional marker chromosomes of unknown origin were generally detected in each cell.
	
	
		Cytogenetics Comments: This is a hyper-triploid human cancer cell line with a modal chromosome number of 79.
	
	
		A Y chromosome was verified by QM staining and C-banding. Normal chromosomes 10, 15 and 17 were absent.
	
	
		The composite karyotype consists of 65 to 84, XY, +1, -2, der(2)t(2;?18)(q10;q10)(x2); -3, del(3)?(pter-->p21::q10-->qter)x2, -4, -5, +6, del(6)(?q15)x2,+7,+8,-9,-10,-10,-10, der(10)x2, -11, add(11)(p15)x2, -12, del(12)?(q11q21)[18],
	
	
		-13, +14, der(14)t(14;17)(q10;q10)x2, -15, -15,- 15, der(15)x2, -16, -17, -17, 17, del(17)x2, -18, +19, -20, +21, -22[cp24]
	
	
		Propagation: DMS 79細胞ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: heat-inactivated fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Protocol: Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. Cell counts are approximate since the cells grow in aggregates.
	
	
		Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended
	
	
		Medium Renewal: 2 to 3 times per week
	
	
		Preservation:	Freeze medium: Complete growth medium, 95%; DMSO, 5%
	
	
		Storage temperature: liquid nitrogen phase
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
	
	
		References:	22250: Bepler G, et al. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Oncogene 4: 45-50, 1989. PubMed: 2536917
	
	
		22793: Pettengill OS, et al. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45: 906-918, 1980. PubMed: 6266631
	
	
		23142: Pettengill OS, et al. Animal model for small cell carcinoma of the lung. Effect of immunosuppression and sex of mouse on tumor growth in nude athymic mice. Exp. Cell Biol. 48: 279-297, 1980. PubMed: 6249655
	
	
		24389: . . Lung Cancer 4: 155-161, 1988.